For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later than the drug alteplase, according to a meta-analysis. Researchers found that the likelihood of good recovery was similar between the two treatments.
from Top Health News -- ScienceDaily https://ift.tt/8PFy1XD
Post a Comment